Elboğa Gülçin, Akaltun Mazlum Serdar, Altındağ Özlem, Altındağ Abdurrahman, Aydeniz Ali, Gürsoy Savaş, Gür Ali
Department of Psychiatry, Gaziantep University, Research Hospital, Gaziantep, Turkey.
Department of Physical Medicine and Rehabilitation, Gaziantep University, Research Hospital, Gaziantep, Turkey.
Turk J Phys Med Rehabil. 2019 Mar 22;66(2):134-139. doi: 10.5606/tftrd.2020.2926. eCollection 2020 Jun.
The aim of this study was to investigate the frequency of alexithymia and attention deficit and to evaluate their relationship with the severity of disease in patients with fibromyalgia syndrome (FMS).
A total of 101 patients (6 males, 95 females; mean age 45.0 years; range, 33 to 56 years) who were admitted to Gaziantep University, Medical Faculty, Physical Medicine and Rehabilitation Department between January 2013 and December 2013 and were diagnosed with FMS and 40 healthy volunteers (4 males, 36 females; mean age 41.5 years; range, 31 to 51 years) were enrolled in this study. The Fibromyalgia Impact Questionnaire (FIQ), Hamilton Depression Scale (HAM-D), Toronto Alexithymia Scale-26 (TAS-26), and Jasper-Goldberg Attention Deficit Test (ADT) were applied.
The rate of alexithymia and possible alexithymia was 56.4% and 20.8% in the patients with FMS and 2.5% and 5% in the control group, respectively. The mean TAS-26 score was 60.1±11.7 in the patients with FMS. According to the HAM-D, depressive symptoms were seen in 72.0% and 2.5% of the patients with FMS and healthy controls, respectively.
Our study results confirm the presence of psychiatric comorbidities in patients with FMS and clearly suggest that depression, alexithymia, and attention deficit are high and mutually correlated in FMS patients. Therefore, all patients should be meticulously evaluated for these conditions at the treatment stage.
本研究旨在调查纤维肌痛综合征（FMS）患者述情障碍和注意力缺陷的发生率，并评估它们与疾病严重程度的关系。
选取2013年1月至2013年12月间入住加济安泰普大学医学院物理医学与康复科且被诊断为FMS的101例患者（6例男性，95例女性；平均年龄45.0岁；范围33至56岁）以及40名健康志愿者（4例男性，36例女性；平均年龄41.5岁；范围31至51岁）纳入本研究。应用纤维肌痛影响问卷（FIQ）、汉密尔顿抑郁量表（HAM-D）、多伦多述情障碍量表-26（TAS-26）和贾斯珀-戈德堡注意力缺陷测试（ADT）。
FMS患者中述情障碍和可能述情障碍的发生率分别为56.4%和20.8%，对照组分别为2.5%和5%。FMS患者的TAS-26平均得分为60.1±11.7。根据HAM-D，FMS患者和健康对照组中分别有72.0%和2.5%出现抑郁症状。
我们的研究结果证实FMS患者存在精神共病，并且明确表明抑郁、述情障碍和注意力缺陷在FMS患者中发生率较高且相互关联。因此，在治疗阶段应对所有患者的这些情况进行细致评估。
